logo
[breadcrumb_custom]

Tag: TCRX Shares

News

TCRX’s Stock Market Pendulum: Swinging Between Gains and Losses

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 15.78% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 91.22%. Over the past 30 days, the price of TCRX has leaped by -1.17%. And in the last five days, it has fallen by -6.64%. The market performance of Tscan Therapeutics Inc has been somewhat stable. Over the past year, the company’s

TOST Stock
Finance

A Tale of Resilience: Tscan Therapeutics Inc Amid Stock Market Turbulence

Tscan Therapeutics Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $8.06 on 03/26/24, and the lowest price during that time was $1.62, recorded on 05/01/23. 52-week price history of TCRX Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Tscan Therapeutics Inc’s current trading price is -1.60% away from its 52-week high, while its distance from the 52-week low is 389.51%. The stock’s price range during this period has fluctuated between $1.62 and $8.06. Shares of the company, which operates

Industry

Tscan Therapeutics Inc (TCRX) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Tscan Therapeutics Inc’s current trading price is 1.91% away from its 52-week high, while its distance from the 52-week low is 395.06%. The stock’s price range over this period has fluctuated between $1.62 and $7.87. The company, operating within the financial sector, had a trading volume of approximately 0.53 million for the day, which was noticeably higher than the average daily share volume of 0.15 million over the last 3 months. In terms of market performance, Tscan